[1]魏丹,张旭东.桂枝茯苓胶囊对卵巢早衰大鼠性激素水平及卵巢细胞凋亡的影响[J].西部中医药,2020,33(08):24-29.[doi:10.12174/j.issn.1004-6852.2020.08.07]
　WEI Dan,ZHANG Xudong.Effects of Guizhi Fuling Capsules on the Levels of Sex Hormone and the Apoptosis of Ovarian Cells in Rats with Premature Ovarian Failure[J].Western Journal of Traditional Chinese Medicine,2020,33(08):24-29.[doi:10.12174/j.issn.1004-6852.2020.08.07]
点击复制

桂枝茯苓胶囊对卵巢早衰大鼠性激素水平及卵巢细胞凋亡的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年08期
页码:
24-29
栏目:
出版日期:
2020-08-15

文章信息/Info

Title:
Effects of Guizhi Fuling Capsules on the Levels of Sex Hormone and the Apoptosis of Ovarian Cells in Rats with Premature Ovarian Failure
文章编号:
1004-6852(2020)08-0024-06
作者:
魏丹，张旭东
中国人民解放军第105医院药剂科，安徽 合肥 230031
Author(s):
WEI Dan, ZHANG Xudong
Pharmacy Department, China People′s Liberation Army No. 105 Hospital, Hefei 230031, China
关键词:
桂枝茯苓胶囊; 卵巢早衰; 性激素; 作用机制
Keywords:
Guizhi Fuling capsules;  premature ovarian failure;  sex hormone;  mechanism
分类号:
R285
DOI:
10.12174/j.issn.1004-6852.2020.08.07
文献标志码:
A
摘要:
目的：观察桂枝茯苓胶囊对卵巢早衰(premature ovarian failure，POF)大鼠性激素水平、卵巢细胞凋亡的改善作用，并探讨其作用机制。方法：取50只健康雌性大鼠，其中40只采用腹腔注射环磷酰胺建立POF大鼠模型，将其随机分为POF组，桂枝茯苓胶囊低、中、高剂量组，剩余10只腹腔注射无菌生理盐水，设为对照组。桂枝茯苓胶囊低、中、高剂量组大鼠分别灌胃0.6、1.2、2.4 g/kg桂枝茯苓胶囊悬浮液2 mL，每日1次，POF组和对照组灌胃生理盐水2 mL，每日1次，连续4周。对比各组血清卵泡刺激激素(follicle stimulating hormone，FSH)、促黄体生成素(luteinizing hormone，LH)及雌二醇(estrogen，E2)水平；观察卵巢组织病理学改变，并对比各组卵巢细胞凋亡情况；对比卵巢组织中丝裂原活化蛋白激酶(p-38 mitogen-activated protein kinase，p-38 MAPK)、凋亡相关因子(factor associated suicide，Fas)、Fas配体(factor associated suicide ligand，FasL)、天冬氨酸特异性半胱氨酸蛋白酶3(Caspase-3)mRNA和蛋白表达情况，对比p-p38 MAPK/p38 MAPK蛋白比值。结果：血清FSH、LH由低到高、E2由高到低依次如下:对照组、桂枝茯苓胶囊高、中、低剂量组，POF组，每2组间比较差异均有统计学意义(P＜0.05)；卵巢组织病理学观察，对照组卵巢体积、各级卵泡细胞、黄体发育正常；POF组卵巢萎缩、卵泡、黄体少，闭锁卵泡增多；桂枝茯苓胶囊组各级卵泡细胞生长情况较POF组改善，其中高剂量组有明显改善；卵巢细胞凋亡率、卵巢组织中Fas、FasL、Caspase-3 mRNA和蛋白相对表达量、p-p38 MAPK/p-38 MAPK蛋白比值由低到高依次为对照组、高、中、低剂量组，POF组，每两组间比较差异均有统计学意义(P＜0.05)；p-38 MAPK mRNA相对表达量比较，差异无统计学意义(P＞0.05)。结论：桂枝茯苓胶囊可显著改善POF大鼠性激素水平、减少卵巢细胞凋亡，其中中剂量组效果最佳，可能与抑制Fas/FasL信号通路有关。
Abstract:
Objective: To survey the effects of Guizhi Fuling capsules on improving the levels of sex hormone and the apoptosis of ovarian cells in the rats with premature ovarian failure (POF), and explore its mechanism. Methods: All 50 healthy female rats were chosen, among them, 40 ones were prepared into POF rat models using intraperitoneal injection of cyclophosphamide, and divided into POF group, low, moderate and high doses groups randomly, the remaining ten rats accepted intraperitoneal injection of sterile normal saline and they were set as the control group. Low, moderate and high doses groups were drenched with Guizhi Fuling capsules respectively in the concentrations of 0.6, 1.2 and 2.4 g/kg, POF group and the control group with normal saline, 2 mL, once each day, for four weeks consecutively. To investigate the levels of FSH, LH and E2 between different groups; to observe histopathological changes of ovary, compare the apoptosis of ovarian cells in different groups; to survey the expressions of p-38 MAPK, Fas, FasL, Caspase-3mRNA and protein in ovarian tissue, and explore p-38 MAPK/p38MAPK protein ratio. Results: FSH and LH from low to high, and E2 from high to low were as follows: the control group, high dose group, moderate dose group, low dose group and POF group, the differences were significant between every two groups (P＜0.05); histopathological observation of ovary, ovarian volume, different levels of ovarian cells and corpus luteum developed normally in the control group; ovarian shrank, ovarian follicle amd corpus luteum lessened, atresia follicle increased in POF group; the growth of follicle cells at different levels in low, moderate and high doses groups were improved compared with these of POF group, among them, it was improved notably in high dose group; apoptosis rate of ovarian cells, the relative expressions of Fas, FasL, Caspase-3mRNA and protein in ovarian tissue, the ratio of p-38 MAPK/p38MAPK ranked from low to high as follows: the control group, high dose group, moderate dose dose group, low dose group and POF group, the differences were significant between every two groups (P＜0.05); the difference was insignificant in the relative expression of p-38 MAPK mRNA (P＞0.05). Conclusion: Guizhi Fuling capsules could significantly improve the levels of sex hormone in POF rats, reduce the apoptosis of ovarian cells, the effects are the best in the concentration of 1.2 g/kg, and it might be related to inhibiting Fas/FasL signaling pathway.

相似文献/References:

[1]康开彪,王贵霞,王晓萍,等.四物汤免疫作用改善卵巢早衰症状的研究现状[J].西部中医药,2013,26(02):119.
　KANG Kaibiao,WANG Guixia,WANG Xiaoping,et al.Status Quo of Immune Function of SiWuTang Improving the Symptoms of Premature Ovarian Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(08):119.
[2]姚彬,朱艳,张慧君.桂枝茯苓胶囊联合米非司酮治疗子宫腺肌病的临床疗效[J].西部中医药,2015,28(01):75.
[3]魏平.桂枝茯苓胶囊联合米非司酮治疗子宫肌瘤43例[J].西部中医药,2014,27(10):116.
[4]刘晓红.桂枝茯苓胶囊联合三苯氧胺治疗卵巢囊肿43例[J].西部中医药,2019,32(08):101.
　LIU Xiaohong.Guizhi Fuling Capsules Joined with Tamoxifen in the Treatment for 43 Cases of Oophoritic Cyst[J].Western Journal of Traditional Chinese Medicine,2019,32(08):101.
[5]张凤凤,崔晓萍,赵潘婷,等.崔晓萍主任医师治疗卵巢早衰经验撷英[J].西部中医药,2022,35(02):48.[doi:10.12174/j.issn.2096-9600.2022.02.12]
　ZHANG Fengfeng,CUI Xiaoping,ZHAO Panting,et al.Chief Physician Cui Xiaoping′s Experience in Treating Premature Ovarian Failure[J].Western Journal of Traditional Chinese Medicine,2022,35(08):48.[doi:10.12174/j.issn.2096-9600.2022.02.12]
[6]刘小娟,石文英,谭志高,等.针刺治疗卵巢早衰临床疗效Meta分析[J].西部中医药,2022,35(09):73.[doi:10.12174/j.issn.2096-9600.2022.09.14]
　LIU Xiaojuan,SHI Wenying,TAN Zhigao,et al.Clinical Effects of Acupuncture in the Treatment of Premature Ovarian Failure: A Meta analysis[J].Western Journal of Traditional Chinese Medicine,2022,35(08):73.[doi:10.12174/j.issn.2096-9600.2022.09.14]
[7]张欢欢,曾丽盈,李莉.基于网络药理学的仙茅-淫羊藿药对治疗卵巢早衰机制研究[J].西部中医药,2022,35(11):52.[doi:10.12174/j.issn.2096-9600.2022.11.10]
　ZHANG Huanhuan,ZENG Liying,LI Li.The Effects of Xianmao-Yinyanghuo Couplet Medicines on Premature Ovarian Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(08):52.[doi:10.12174/j.issn.2096-9600.2022.11.10]
[8]刘安琪,陈梅,李楠,等.从“瘀”论治卵巢早衰[J].西部中医药,2023,36(08):38.[doi:10.12174/j.issn.2096-9600.2023.08.10]
　LIU Anqi,CHEN Mei,LI Nan,et al.Treatment of Premature Ovarian Failure from Blood Stasis[J].Western Journal of Traditional Chinese Medicine,2023,36(08):38.[doi:10.12174/j.issn.2096-9600.2023.08.10]
[9]邓星佑,林忆平,吴向农,等.疏调气机法联合桂枝茯苓胶囊治疗子宫肌瘤的疗效及其对血清TGF-β1、TSGF的影响[J].西部中医药,2024,37(01):139.[doi:10.12174/j.issn.2096-9600.2024.01.28]
　DENG Xingyou,LIN Yiping,WU Xiangnong,et al.Therapeutic Effects of Regulating Qi Flow Method and Guizhi Fuling Capsules in the Treatment of Hysteromyoma and Its Influence on the Levels of Serum TGF-β1 and TSGF[J].Western Journal of Traditional Chinese Medicine,2024,37(08):139.[doi:10.12174/j.issn.2096-9600.2024.01.28]

备注/Memo

备注/Memo:
收稿日期：2019-09-24作者简介：魏丹(1987—)，女，主治医师。研究方向：医院药库药品管理。
更新日期/Last Update: 2020-08-15